PRS40 THE IMPACT OF THE FDAS RISK EVALUATION AND MITIGATION STRATEGIES (REMS) INITIATIVE ON PRESCRIPTION PATTERN FOR DRUGS APPROVED UNDER THE REMS PROGRAM AND RELEVANT NON-REMS COMPETITORS
May 1, 2010, 00:00
10.1016/S1098-3015(10)72993-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)72993-4/fulltext
Title :
PRS40 THE IMPACT OF THE FDAS RISK EVALUATION AND MITIGATION STRATEGIES (REMS) INITIATIVE ON PRESCRIPTION PATTERN FOR DRUGS APPROVED UNDER THE REMS PROGRAM AND RELEVANT NON-REMS COMPETITORS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72993-4&doi=10.1016/S1098-3015(10)72993-4
First page :
Section Title :
Open access? :
No
Section Order :
585